New receptor ‘decoy’ drug neutralizes COVID-19 virus and its variants
Scientists have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug is designed in such a way that natural selection to maintain infectiousness of the virus should also maintain the drug’s activity against future variants.
Materials provided by Dana-Farber Cancer Institute. Note: Content may be edited for style and length.
Source link aaaaa